Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Reinaldo N. Takahashi"'
Autor:
Fernanda da Rosa, Nuno J. Machado, Pablo Pandolfo, Cristiane Ribeiro de Carvalho, Carolina Melo de Souza, Lisiane O. Porciúncula, Rodrigo A. Cunha, Douglas Teixeira Leffa, Grasielle C. Kincheski, Diogo O. Souza, Samira G. Ferreira, Reinaldo N. Takahashi
Publikováno v:
European Journal of Neuroscience. 49:1673-1683
Attention deficit and hyperactivity disorder (ADHD) is characterized by impaired levels of hyperactivity, impulsivity, and inattention. Adenosine and endocannabinoid systems tightly interact in the modulation of dopamine signaling, involved in the ne
Publikováno v:
Neuroscience Letters. 380:270-275
Δ9-THC and synthetic cannabinoids produce memory impairment in humans as well as in laboratory animals. The high concentration of cannabinoid CB1 receptors and the presence of endocannabinoids in the hippocampus suggest that a cannabinoid neurochemi
Publikováno v:
Neuroscience Letters. 349:49-52
The effect of systemic administration of the cannabinoid antagonist SR 141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide) on penile erection and yawning induced by apomorphine was investigated in rats. SR 141716A (2 m
Publikováno v:
Neuroscience letters. 470(1)
Evidence are that inhibition of cyclooxygenase 2 (COX-2) enhances endocannabinoid signaling, indicating a crosstalk between these two eicosanoid pathways. Aspirin, a non-selective COX inhibitor, acetylates COX-2 with generation of a lipoxygenase (LOX
WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors
Publikováno v:
Neuroscience letters. 397(1-2)
The memory deficits induced by cannabinoid agonists have been found in several behavioral paradigms. Nevertheless, there is evidence that not all types of memory are impaired after cannabinoid administration. The aim of this study was to investigate